Evaluation of the Role of Soluble Receptors for Advanced Glycosylated End-Products in Polycystic Ovarian Syndrome

    Hossam Hassan Aly Hassan El Sokkary, Mona Sobhy, Wafaa Mostafa Abo Elenein, Heba Elesawy Mohamed
    Studysummary This study observed that women with polycystic ovarian syndrome had higher serum SRAGE levels compared to controls, but the difference was not statistically significant.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006